DZ Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.4M Buy
52,779
+18,874
+56% +$7M 0.02% 281
2026
Q1
$9.93M Sell
33,905
-12,725
-27% -$4.18M 0.01% 385
2025
Q4
$16.3M Sell
46,630
-5,624
-11% -$1.9M 0.01% 299
2025
Q3
$16.9M Sell
52,254
-13,691
-21% -$4.26M 0.01% 304
2025
Q2
$25.6M Buy
65,945
+4,272
+7% +$1.72M 0.03% 226
2025
Q1
$26.8M Buy
61,673
+54,118
+716% +$21.7M 0.03% 216
2024
Q4
$2.79M Sell
7,555
-26,671
-78% -$11.2M ﹤0.01% 519
2024
Q3
$17.8M Buy
34,226
+25,828
+308% +$13.8M 0.02% 282
2024
Q2
$4.55M Sell
8,398
-2,902
-26% -$1.53M ﹤0.01% 478
2024
Q1
$5.86M Sell
11,300
-45,727
-80% -$22.7M 0.01% 443
2023
Q4
$26.9M Sell
57,027
-11,562
-17% -$5.35M 0.03% 230
2023
Q3
$29.9M Buy
68,589
+1,964
+3% +$891K 0.04% 208
2023
Q2
$29.6M Sell
66,625
-15,315
-19% -$7.07M 0.04% 204
2023
Q1
$37.7M Sell
81,940
-4,817
-6% -$2.29M 0.06% 185
2022
Q4
$44.5M Buy
86,757
+20,089
+30% +$10.2M 0.08% 164
2022
Q3
$30.3M Sell
66,668
-734,706
-92% -$352M 0.06% 193
2022
Q2
$387M Sell
801,374
-275,518
-26% -$136M 0.7% 40
2022
Q1
$529M Sell
1,076,892
-431,078
-29% -$197M 0.76% 40
2021
Q4
$704M Buy
1,507,970
+1,297,381
+616% +$546M 0.5% 51
2021
Q3
$78.5M Buy
210,589
+95,870
+84% +$36.4M 0.12% 116
2021
Q2
$43.8M Sell
114,719
-116,875
-50% -$44.7M 0.07% 177
2021
Q1
$83.1M Sell
231,594
-686,379
-75% -$221M 0.15% 106
2020
Q4
$288M Sell
917,973
-680,393
-43% -$209M 0.58% 45
2020
Q3
$429M Buy
1,598,366
+266,114
+20% +$71.6M 1.03% 23
2020
Q2
$350M Buy
1,332,252
+42,193
+3% +$11.3M 0.94% 27
2020
Q1
$293M Sell
1,290,059
-267,600
-17% -$72.9M 0.99% 23
2019
Q4
$476M Buy
1,557,659
+611,901
+65% +$168M 1.25% 18
2019
Q3
$227M Buy
945,758
+76,399
+9% +$20.9M 0.68% 49
2019
Q2
$245M Buy
869,359
+3,513
+0.4% +$960K 0.76% 35
2019
Q1
$248M Buy
865,846
+398,144
+85% +$115M 0.81% 36
2018
Q4
$121M Sell
467,702
-16,439
-3% -$4.52M 0.47% 64
2018
Q3
$133M Sell
484,141
-3,356
-0.7% -$871K 0.47% 67
2018
Q2
$116M Buy
487,497
+5,157
+1% +$1.19M 0.43% 70
2018
Q1
$106M Buy
482,340
+18,738
+4% +$4.4M 0.41% 70
2017
Q4
$104M Sell
463,602
-294,026
-39% -$62.6M 0.4% 74
2017
Q3
$144M Sell
757,628
-26,580
-3% -$5.06M 0.6% 50
2017
Q2
$148M Sell
784,208
-2,525
-0.3% -$454K 0.68% 47
2017
Q1
$130M Buy
786,733
+410,874
+109% +$65.4M 0.59% 57
2016
Q4
$54M Buy
+375,859
New +$50.3M 0.26% 112

Other funds holding ELV

DZ Bank's ELV Position: Q2 2026 in Review

DZ Bank increased its Elevance Health (ELV) stake by 56% in Q2 2026, buying an estimated $7M and bringing the position to 52,779 shares worth $20.4M. The position accounts for 0.02% of the portfolio, ranked #281.

DZ Bank first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. The position peaked at $704M in Q4 2021. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • DZ Bank held 52,779 shares of Elevance Health worth $20.4M as of Q2 2026.
  • DZ Bank bought 18,874 Elevance Health shares in Q2 2026, an estimated $7M.
  • Elevance Health made up 0.02% of DZ Bank's portfolio in Q2 2026, its #281 holding.
  • DZ Bank first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
  • DZ Bank's Elevance Health position peaked at $704M in Q4 2021.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.